웹Hyperglycemia is a causative factor in the pathogenesis of respiratory diseases, known to induce fibrosis and inflammation in the lung. However, little attention has been paid to genes related to hyperglycemic-induced lung alterations and stem cell applications for therapeutic use. In this study, our microarray data revealed significantly increased levels of junctional … 웹19시간 전 · The basilar artery (U.K.: / ˈ b æ z. ɪ. l ə /; U.S.: / ˈ b æ s. ə. l ər /) is one of the arteries that supplies the brain with oxygen-rich blood.. The two vertebral arteries and the basilar artery are known as the vertebral basilar …
Acenocoumarol-Induced Diffuse Alveolar Hemorrhage: A Case …
웹2024년 10월 30일 · Citation, DOI, disclosures and article data. Air space opacification is a descriptive term that refers to the filling of the pulmonary tree with material that attenuates x-rays more than the surrounding lung parenchyma . It is one of the many patterns of lung opacification and is equivalent to the pathological diagnosis of pulmonary consolidation. 웹2024년 1월 23일 · What every physician needs to know: Several pulmonary conditions occur in association with underlying liver disease. Ascites elevates the diaphragms and causes basilar atelectasis, which contributes to dyspnea and mild hypoxia. Some patients with ascites have diaphragmatic defects that allow ascites fluid to flow into the chest, causing a pleural … ctflearn forensics绫籈xif
A Fatal Case of Diffuse Alveolar Hemorrhage in the Setting of …
웹Airspace disease can be acute or chronic and commonly present as consolidation or ground-glass opacity on chest imaging. Consolidation or ground-glass opacity occurs when … 웹2024년 4월 14일 · Diffuse alveolar hemorrhage (DAH) is bleeding into the alveolar spaces of the lung. DAH is often associated with systemic autoimmune diseases, coagulation disorders, drugs, inhaled toxins, or transplantation. This study describes a rare case of acenocoumarol-induced DAH, a pulmonary disorder, which has not been reported before. A 48-year-old … 웹Provided is an siRNA conjugate targeting FAP-positive cells, comprising: a ligand portion targeting FAP, an siRNA portion that inhibits expression of survival genes in FAP-positive cells, and a linker portion located between the ligand portion and siRNA portion. Also provided are a method for preparing the siRNA conjugate, and a pharmaceutical composition and use of … ct flea markets 2011